In this interview Mark A. Preston, MD, MPH, of Brigham and Women’s hospital sat down with Richard. R. Kerr, Urology Times content channel director, to discuss the association between obesity and incidence of total and fatal renal cell carcinoma in two prospective cohorts. The interview was conducted during the AUA annual meeting in New Orleans.
A large-scale study provides new evidence that targeted MRI ultrasound fusion prostate biopsy increases detection of high risk prostate cancers while decreasing detection of low-risk cancers. "More reliable diagnosis"
Members of the Large Urology Group Practice Association will gather Nov. 6-8 in Chicago for the association’s annual meeting, and Urology Times will be delivering highlights of the meeting straight to your inbox.
Papers examining the effects of diet and substance use on male fertility presented at the recently concluded American Society for Reproductive Medicine annual meeting in Honolulu may appear to provide conflicting findings, but an expert in andrology says the observational studies don’t tell the complete story.
Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Prolaris prostate cancer test, Myriad Genetics, Inc. announced.